Former PHAS professor Carl Hansen featured in media for successful AbCellera IPO

December 14, 2020
News Thumbnail Caption
Dr. Carl Hansen. Credit: Michael Smith Laboratory.

Congratulations to former UBC Physics & Astronomy associate professor Carl Hansen for an extremely successful initial public offering of AbCellera, where he is the founding Chief Executive Officer. The company, now worth US $15-billion, utilizes an innovative assay technology that allows for rapid discovery of antibodies. The company spearheaded the development of an antibody treatment for COVID-19, which was recently granted by Health Canada for use in recently diagnosed, mild to moderate COVID-19 in high-risk patients.

This IPO sets the record for the biggest debut for a Canadian biotechnology company. 

Carl joined UBC in 2005, and left the department in fall 2019 to pursue his commitment as Chief Executive Officer of AbCellera.

Media features on this success

More about AbCellera

Carl is also an alumnus of our Engineering Physics Program; the Program shared some highlights of Carl's career through an Instagram post below.

Congratulations again Carl and the AbCellera team!